We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+12.81%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$283M
AUM Growth
+$162M
Cap. Flow
+$72.6M
Cap. Flow %
25.66%
Top 10 Hldgs %
42.53%
Holding
215
New
70
Increased
65
Reduced
14
Closed
66

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$2.38M
2
WMT icon
Walmart Inc
WMT
+$2.38M
3
JPM icon
JPMorgan Chase
JPM
+$2.13M
4
FATE icon
Fate Therapeutics
FATE
+$1.92M
5
FTNT icon
Fortinet
FTNT
+$1.5M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$2.05M
2
PFE icon
Pfizer
PFE
+$1.44M
3
CVS icon
CVS Health
CVS
+$1.41M
4
MET icon
MetLife
MET
+$1.4M
5
DE icon
Deere & Co
DE
+$1.24M

Sector Composition

Rank Sector Weight
1 Financials 18.71%
2 Technology 15.05%
3 Industrials 8.12%
4 Healthcare 7.38%
5 Energy 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALB icon
151
Albemarle
ALB
$15.3B
– –
-2,632
Closed -$696K
AMWD
152
DELISTED
American Woodmark
AMWD
– –
-11,321
Closed -$496K
BIIB icon
153
Biogen
BIIB
$30.1B
– –
-3,663
Closed -$978K
CE icon
154
Celanese
CE
$4.92B
– –
-2,488
Closed -$224K
CLH icon
155
Clean Harbors
CLH
$16.4B
– –
-4,900
Closed -$538K
CMA
156
DELISTED
Comerica
CMA
– –
-7,284
Closed -$517K
CNC icon
157
Centene
CNC
$32.1B
– –
-9,064
Closed -$705K
CNM icon
158
Core & Main
CNM
$8.73B
– –
-25,121
Closed -$571K
CRWD icon
159
CrowdStrike
CRWD
$226B
– –
-18,964
Closed -$781K
CSL icon
160
Carlisle Companies
CSL
$15.5B
– –
-2,841
Closed -$796K
CSX icon
161
CSX Corp
CSX
$92.5B
– –
-26,106
Closed -$695K
CTRA
162
DELISTED
Coterra Energy
CTRA
– –
-29,899
Closed -$780K
CVS icon
163
CVS Health
CVS
$120B
– –
-14,800
Closed -$1.41M
DE icon
164
Deere & Co
DE
$167B
– –
-3,710
Closed -$1.24M
DRH icon
165
Diamondrock Hospitality Co
DRH
$2.46B
– –
-67,042
Closed -$503K
DV icon
166
DoubleVerify
DV
$2.03B
– –
-22,577
Closed -$617K
ETN icon
167
Eaton
ETN
$178B
– –
-5,202
Closed -$693K
EWBC icon
168
East-West Bancorp
EWBC
$18.2B
– –
-7,980
Closed -$535K
FNB icon
169
FNB Corp
FNB
$6.8B
– –
-43,378
Closed -$503K
GDYN icon
170
Grid Dynamics Holdings
GDYN
$630M
– –
-29,984
Closed -$561K
GMS
171
DELISTED
GMS Inc
GMS
– –
-12,263
Closed -$490K
GTLB icon
172
GitLab
GTLB
$7.11B
– –
-10,390
Closed -$532K
HAL icon
173
Halliburton
HAL
$28.2B
– –
-31,658
Closed -$779K
HUBG icon
174
HUB Group
HUBG
$2.32B
– –
-15,976
Closed -$551K
JBHT icon
175
JB Hunt Transport Services
JBHT
$24.9B
– –
-4,637
Closed -$725K
5 6
7
8 9

Similar funds

CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
PC
Prysm Capital Princeton, New Jersey $10.6M AUM 2.38% 1-Year Est. Return
CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
AVM
Altos Ventures Management Burlingame, California $11.7M AUM 182.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return

Alpha DNA Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Alpha DNA Investment Management held 215 positions worth $283M, up 135% from $120M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Alpha DNA Investment Management deployed $72.6M of net new capital in Q4 2022, opening 70 new positions and adding to 65 existing holdings. Its largest new stake was Fate Therapeutics: 102,094 shares worth $1.03M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was ExxonMobil, an estimated $2.05M trimmed.

  • Alpha DNA Investment Management's largest Q4 2022 buy was Fate Therapeutics: 102,094 shares worth $1.03M.
  • Alpha DNA Investment Management added most to McDonald's in Q4 2022, an estimated $2.38M increase.
  • Alpha DNA Investment Management's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $2.05M.
  • Alpha DNA Investment Management fully exited CVS Health in Q4 2022, selling an estimated $1.41M.
  • Alpha DNA Investment Management's ten largest holdings make up 43% of its $283M portfolio in Q4 2022.
  • Alpha DNA Investment Management opened 70 new positions and closed 66 in Q4 2022.
  • Alpha DNA Investment Management's portfolio value rose 135% quarter-over-quarter to $283M.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.